Join our benefit experts on June 19th for a session on Drug Plan Management and Sustainability in the Age of High Cost Drugs. With the potential that a single high cost drug could threaten the sustainability of a benefits plan, plan sponsors are facing increasingly difficult decisions on drug plan design. Should you delist biologics? Should you implement a plan maximum? What are the risks? Our experts will discuss the options for mitigating your legal, financial and reputational risks when it comes to high cost drug plan management.
This session will be of interest to human resources, finance and employment law professionals.
Lori Park, Partner and Atlantic Canada's Market Leader
Tara Anstey, Principal
Mike Horne, Principal
Register for Mercer's "HR Knowledge Seminar Series: Drug Plan Management"
June 19, 2018, St. John's, Newfoundland
1:00 PM - 6:00 PM (NT)
THIS EVENT HAS PASSED
REGISTRATION WILL OPEN 4 WEEKS PRIOR TO EVENT DATE.